The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saijo, S.
Right arrow Articles by Iwakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saijo, S.
Right arrow Articles by Iwakura, Y.
The Journal of Immunology, 1999, 163: 5700-5707.
Copyright © 1999 by The American Association of Immunologists

Bone Marrow-Derived Cells Are Responsible for the Development of Autoimmune Arthritis in Human T Cell Leukemia Virus Type I-Transgenic Mice and Those of Normal Mice Can Suppress the Disease1

Shinobu Saijo*, Motoko Kotani*, Kiyoshi Habu*, Chiho Ishitsuka*, Hiroaki Yamamoto{dagger}, Toyozo Sekiguchi{dagger} and Yoichiro Iwakura2,*

* Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan; and {dagger} Kohno Clinical Medicine Research Institute, Tokyo, Japan


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previously, we reported that human T cell leukemia virus type I env-pX region-introduced transgenic (pX-Tg) mice developed an inflammatory polyarthropathy associated with a development of autoimmunity. To elucidate roles of autoimmunity in the development of arthritis, the immune cells were reciprocally replaced between pX-Tg mice and non-transgenic (Tg) mice. When bone marrow (BM) cells and spleen cells from pX-Tg mice were transferred into irradiated non-Tg mice, arthritis developed in these mice. In contrast, arthritis in pX-Tg mice was completely suppressed by non-Tg BM and spleen cells. Similar results were obtained with BM cells only. After the transplantation, T cells, B cells, and macrophages were replaced completely, whereas cells in the joints were replaced partially. In those mice, serum Ig and rheumatoid factor levels correlated with the disease development, and inflammatory cytokine expression was elevated in the arthritic joints. Furthermore, involvement of T cells in the joint lesion was suggested, because the incidence was greatly reduced in athymic nu/nu mice although small proportion of the mice still developed arthritis. These observations suggest that BM stem cells are abnormal, causing autoimmunity in pX-Tg mice, and this autoimmunity plays an important, but not absolute, role in the development of arthritis in this Tg mouse.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Rheumatoid arthritis (RA)3 is a systemic, chronic inflammatory disorder that mainly affects the joints. Because RA patients often develop Abs and cellular immunity against various self-substances including IgG (1), type II collagen (IIC) (2, 3, 4), and heat shock proteins (5), immune reactions against these molecules are suspected to play important roles in the pathogenesis of the disease. However, thus far the pathogenic roles of the autoimmunity in the development of RA have not been elucidated completely.

Human T cell leukemia virus type I (HTLV-I) is the causative agent of adult T cell leukemia (6). This virus encodes a transcriptional trans-activator, Tax, in the env-pX region, that trans-activates transcription from the cognate viral promoter through the 21 bp enhancer (7). Tax also activates many cellular genes (8), including these for cytokines (9, 10, 11, 12), cytokine receptors (13, 14), and immediate early transcriptional factors (15, 16) through activation of enhancers such as the NF-{kappa}B-dependent enhancers or serum-responsive elements (7). Previously, we found that Tg mice carrying the HTLV-1 env-pX region with its own long terminal repeat (LTR) promoter developed chronic inflammatory polyarthropathy at a high incidence (17). The arthritis develops in multiple joints as early as 4 wk of age, and at 3 mo of age, 60% (BALB/cAn background) and 20% (C3H/HeN background) of the mice are affected. The histopathology is very similar to that of RA in humans, showing marked synovial and periarticular inflammation with articular erosion caused by invasion of granulation tissues. These mice develop autoimmunity with elevated levels of Abs against IgG, IIC, and heat shock proteins and show IgG hypergammaglobulinemia in which agalactosylated forms of the Ig carbohydrate chains increase (18). In this regard, we recently found that T cells from HTLV-I env-pX region-introduced transgenic (pX-Tg) mice were refractory against anti-Fas Ab treatment (19). This finding suggests that this defect may be involved in the development of autoimmunity in these mice, because Fas-mediated apoptosis of T cells is believed to be important in eliminating autoreactive T cells in the periphery (20). Furthermore, various genes including inflammatory cytokine genes such as IL-1{alpha}, IL-1ß, IL-6, TNF-{alpha}, and IFN-{gamma} genes, immediate early genes such as c-fos and c-jun, and class I and class II MHC genes are activated in the Tg joints (18, 21), probably because of the transcriptional trans-activating activity of the tax gene and also as a result of immune reactions in the affected joints in later stage. Because similar abnormalities are also found in RA patients, we think pX-Tg mice provide a good disease model for RA.

Although the pathogenesis of arthritis in this Tg mouse has not been elucidated completely, several possibilities are conceivable. One is that Tax-induced overproduction of inflammatory cytokines as well as immediate early gene products in the synovial cells may directly cause synovial cell growth and bone erosion. Actually, it was shown that overproduction of TNF-{alpha} in the joints caused arthritis in Tg mice without involvement of immune reaction (22). IL-1{alpha} also causes arthritis when it is injected into rabbit joints (23), indicating the arthritogenic nature of these cytokines. Another possibility is that the autoimmunity that developed in these Tg mice is involved in the onset of the disease, as is suggested in RA cases (24). In this connection, it is well known that immunization of DBA1 mice with IIC causes arthritis (25). pX-Tg mice also have the Ab against IIC, and immunization with IIC augments the development of arthritis, suggesting that immune reaction against IIC may be involved in the pathogenesis (18).

In this study, the roles of the immune cells in the development of arthritis in pX-Tg mice were examined to discriminate these possibilities. For this, we conducted reciprocal replacement of the immune system between pX-Tg and normal mice. Furthermore, we examined the incidence of arthritis in athymic trangenic mice by introducing the nu gene into pX-Tg mice. The results show that immune cells, but not synovial resident cells, are primarily responsible for the development of the disease.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

The original Tg mouse was produced by injecting the pX and env region of the HTLV-I genome with its own promoter into fertilized mouse ova from (C3H/HeN x C57BL/6J)F1 intercrosses (17). Then, they were backcrossed to BALB/cAn mice, and littermates at the age of 2–3 mo of backcross generations 8 to 11 were used for the experiments. The transgene was detected by dot blot hybridization of the tail DNA (18), and the transgene-positive and -negative mice are designated pX-Tg and non-Tg mice, respectively.

Male BALB/c-nu/nu mice were obtained from Charles River Japan (Kanagawa, Japan). They were crossed to pX-Tg females, and female progenies carrying the transgene were crossed with male nude mice again. Then, pX-positive hairless (nu/nu) and hairy (nu/+) mice were examined for the development of arthritis.

All the mice were kept under specific pathogen-free conditions in environmentally controlled clean rooms in the Laboratory Animal Research Center, Institute of Medical Science, University of Tokyo (Tokyo, Japan). The experiments were conducted according to the institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation experiments.

BM and spleen cell transfer

old pX-Tg and non-Tg female mice, 6–8 wk old, were used as donors of BM and spleen cells. BM cells were prepared from the femurs and tibiae and were used directly (BM cells) or after treatment with mouse anti-Thy-1.2 Ab (Serotec, Oxford, U.K.) and rabbit complement (Technically, Hornby Ontario, Canada) (T cell-depleted BM cells). Age- and sex-matched recipient mice were irradiated with 7.5 Gy of gamma-rays and, after 6 h, were injected with either 107 viable BM cells only or 107 viable spleen cells with 106 BM cells i.v.

Clinical evaluation

Arthritis was evaluated macroscopically. The joints of each paw were examined weekly for swelling and redness, and the disease severity was graded from 0 to 3 (grade 0 = no special changes; grade 1 = light swelling and/or redness of the joint; grade 2 = obvious swelling; grade 3 = fixation of the joint). The score of the four paws were totaled and used as severity score (0–12 points in individual mice).

Histopathology

All of the BM cell-transferred mice and nude mice were submitted to autopsy after inspection for the development of arthritis for 26–30 wk. The limbs were fixed in 10% neutral formalin and, after decalcification with 5% formic acid, embedded in paraffin, sectioned at 4 µm, and stained with hematoxylin and eosin.

Ab titration

Serum levels of IgG rheumatoid factor (RF) were determined by ELISA as previously described (18). Briefly, polyvinyl microtiter plates (Falcon Micro Test III, Becton Dickinson, Tokyo, Japan) were coated with 50 µl heat-denatured rabbit IgG (10 µg/ml) in PBS overnight at 4°C. For total IgG and total IgM, the plates were coated with anti-mouse Ig (DAKO, Kyoto, Japan; 1/10,000 dilution). After a washing with TBS (25 mM Tris-HCl and 140 mM NaCl, pH 7.4), the plates were blocked with 1% skim milk (Difco), 5 mM EDTA, 0.02% NaN3, TBS (blocking buffer) for 1 h at room temperature. Then, 50 µl blocking buffer-diluted mouse serum were added to each well and incubated for 1 h at room temperature followed by washing with 0.05% Tween 20-TBS. Fifty microliters of alkaline phosphatase-conjugated goat anti-mouse IgG Ab or IgM (Zymed; 1/500 dilution) in the blocking buffer was added as the second Ab and incubated at room temperature for 1 h. After a washing with Tween 20-TBS, 100 µl of 1 mg/ml p-nitrophenylphosphate (Sigma, St. Louis, MO) in 50 mM NaHCO3, 5 mM MgCl2 (pH 9.5) was added, and the optical density at 415 nm was measured by an ELISA microreader (MTP-120, Colona, Tokyo, Japan) after incubation at 37°C for 1 h. The Ab levels were calculated with the use of standard positive controls.

Northern blot hybridization and RNase protection assay

Macrophages were collected from the peritoneum after injection with 2% thioglycolate, and T cells were purified from the spleen cells with a nylon wool column. B cells were purified from adherent cell-removed spleen cells by depleting T cells with mouse anti-Thy-1.2 Ab (Serotec) and rabbit complement (Technically). Joint preparation contained the knees, ankles, and the digits from which the skin and the muscle were removed. Then, total RNA was prepared by the acid-guanidinium thiocyanate-phenol-chloroform method (26). Cytokine mRNA was analyzed by Northern blot hybridization using oligo(dT) column-purified poly(A)+ RNA (18). The pX mRNA was measured by RNase protection assay using the total RNA (17). The intensity of the bands on the autoradiogram was estimated by the BAS 2000 system (Fuji-film, Kanagawa, Japan).

Probes

Mouse IL-1{alpha} and IL-1ß cDNA (CDMmIL-1{alpha} and CDMmIL-1ß, respectively) were provided by Dr. Tetsuo Sudo (27, 28), and the XhoI fragments (2.0 and 1.3 kb) were used as probes. Mouse IL-6 (moIL-6) and TNF-{alpha} (moTNF-{alpha}) cDNA were kindly gifted from Dr. Takashi Yokota (29, 30), digested with BamHI (1.2 kb) and BglI-BglII (0.7 kb), respectively, and used as probes.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chronic polyarthritis was induced in non-Tg mice by transferring Tg BM cells

Previously, we reported that pX-Tg mice develop arthritis spontaneously. Those mice began to develop arthritis around 4 wk of age, and the incidence at 30 wk of age was ~80% (Fig. 1Go). To elucidate the roles of autoimmunity in the development of arthritis, we conducted reciprocal reconstitution of the immune system between pX-Tg and non-Tg mice. As shown in Fig. 1GoA, irradiated non-Tg mice transferred with T cell-depleted pX-Tg BM cells ([Tg->non-Tg] mice) developed arthritis 16 wk after the transplantation, and 50% of the mice were affected after 30 wk. Transfer of the pX-Tg spleen cells together with the BM cells or T cell-undepleted BM cells also showed similar results, suggesting that BM cells, but not T cells or B cells, are responsible for the development of this arthritis. The average severity score of the affected joints 30 wk after the transplantation was comparable with that of untreated pX-Tg mice (Fig. 1GoB). No remarkable changes were found in the BM cell populations expressing either CD11b, Gr1, B220, or Thy-1.2 Ags between pX-Tg mice and wild-type mice as analyzed by FACS, excluding a possibility that cell composition is abnormal in Tg mice (data not shown). Thus, these results indicate that BM stem cells are abnormal in pX-Tg mice.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 1. Incidence of arthritis (A and C) and mean arthritic severity score of the affected mice (B and D) after BM cell transplantation. A and B, [Tg->non-Tg]. T cell-depleted BM cells ({triangledown}, n = 8), BM cells plus spleen cells from pX-Tg mice ({blacktriangleup}, n = 10), or BM cells ({triangleup}, n = 9) were transplanted into gamma-ray-irradiated non-Tg mice, and development of arthritis was observed periodically. Control BALB/cAn mice did not develop the disease (···{blacktriangledown}···, n = 32). The incidence and severity score of arthritis in untreated pX-Tg are also shown (···•···, n = 35). C and D, [non-Tg->Tg]. T cell-depleted BM cells ({diamondsuit}, n = 9), BM plus spleen cells from non-Tg mice ({circ}, n = 30), or BM cells (, n = 18) were transferred into gamma-ray-irradiated pX-Tg. [Tg->Tg]. T cell-depleted BM cells ({diamond}, n = 8), BM plus spleen cells from pX-Tg mice ({square}, n = 30), or BM cells ({blacksquare}, n = 15) were transferred into irradiated pX-Tg mice. The incidence of arthritis shows the percentage of affected mice in which the arthritic score is >1. The arthritic score indicates the average arthritic severity score of the affected mice. Arrows indicate the point when the cells were transplanted.

 
The development of arthritis was confirmed microscopically (Fig. 2Go and Table IGo). Bone and cartilage erosion caused by invasion of granuloma-like cells was seen in the affected joints of the [Tg->non-Tg] mice (Fig. 2Go, A--C). Overgrowth of the synovial cells and infiltration of inflammatory cells consisting of neutrophils, lymphocytes, and plasma cells were marked in the joints and periarticular space (Table IGo). Exfoliation of the synovial lining cells was also observed in some mice. These histopathological observations were very similar to those seen in spontaneously developed arthritic joints and show that pX-Tg mouse BM-derived cells are abnormal and are responsible for the development of the disease.



View larger version (167K):
[in this window]
[in a new window]
 
FIGURE 2. Histology of the joints after transplantation of immune cells. A–C, [Tg->non-Tg] mice; D–F, [non-Tg->Tg] mice. A, Ankle joints of a non-Tg mouse transferred with Tg-BM plus spleen cells. Bone and cartilage erosion with infiltration of inflammatory cells can be seen. x20. B, Ankle joints of a non-Tg mouse transferred with Tg-BM cells. Aggressive destruction of the joints. Necrotic changes of the synovial tissue with infiltration of inflammatory cells occurred. x20. C, Ankle joint of a non-Tg mouse transferred with Tg-BM cells. Bone erosion (arrowheads) was marked in association with invasion by fibroblastic cells and inflammatory cells, forming pannus. x100). D, Ankle joints of a Tg mouse transferred with non-Tg BM plus spleen cells. No sign of inflammation or synovial proliferation can be seen. x20. E, Ankle joints of a Tg mouse transferred with non-Tg BM cells. No remarkable changes can be seen. x 20. F, Ankle joints of a Tg mouse transferred with non-Tg BM cells. Augmented proliferation of the synovial lining cells was observed in this mouse joint (arrowheads), and a part of necrotizing cells was scraped off into the synovial space. x100. These mice were sacrificed for autopsy when 32–36 wk old, 26–30 wk after the transplantation.

 

View this table:
[in this window]
[in a new window]
 
Table I. Pathologic score in transferred mice1

 
Development of arthritis in pX-Tg mice was suppressed by the introduction of non-Tg BM cells

Next, we examined whether replacement of the immune cells can prevent development of the disease in pX-Tg mice. As shown in Fig. 1Go, C and D, when BM cells from non-Tg mice were transferred into irradiated Tg mice, the development of arthritis was completely suppressed. The presence of T cells did not affect the results; BM transplantation with spleen cells or T cell-undepleted BM cells transplantation gave the similar results, although the efficiency of the suppression appeared better in BM plus spleen cell transfer. Interestingly, the swelling and redness of the joint became resolved in three of six mice that had already developed arthritis after transplantation of BM plus spleen cells. Under these conditions, the Tg mice that were transplanted with Tg BM plus spleen cells or only BM cells developed arthritis 100%.

Joints had no remarkable histological changes in most [non-Tg->Tg] mice (Fig. 2Go, D and E), in support of the macroscopic observation. However, proliferation of the synovial lining cells as well as fibroblastic cells of the periarticular tissues were observed in some of the [non-Tg->Tg] mice (Fig. 2GoF and Table IGo). This incomplete suppression of the disease was observed more frequently in BM cell-transferred mice than in BM plus spleen cell-transferred mice (Table IGo). Collectively, these results established the primary role of the BM-derived cells in the pathogenesis of arthritis in pX-Tg mice.

The pX transgene was strongly expressed in lymphatic organs, but only weakly in the joints, after transplantation of Tg BM cells

The transgene is expressed in many organs including the joints, spleen, thymus, and muscle in the original pX-Tg mice (17). We examined the expression of the transgene 6 mo after the transplantation of the Tg BM cells into irradiated non-Tg mice to survey the fate of the transferred cells. As shown in Fig. 3Go, the transgene was strongly expressed in T cells including the thymocytes and splenic T cells of [Tg->non-Tg] mice, but the expression was not detected in those of [non-Tg->Tg] mice. Thus, most of the T cells seemed to be replaced by those from donor mice. Transgene expression in macrophages was similarly observed in [Tg->non-Tg] mice but not in [non-Tg->Tg] mice, indicating that this population was also replaced. Transgene expression in B cells was also observed in [Tg->non-Tg] mice, but not in [non-Tg->Tg] mice. In contrast, replacement of the synovial cells in the joints seemed to occur only partially, because the pX expression was still observed in [non-Tg->Tg] mouse joints and that in the [Tg->non-Tg] mouse joints was lower than that of Tg mice (Fig. 3Go). These observations suggest that BM-derived cells such as T cells, B cells, or macrophages are responsible for the development of arthritis, but resident cells in the joint are not directly involved.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 3. The pX mRNA expression in BM cell-transferred mice. The pX-mRNA expression was analyzed by RNase protection assay. Total RNA was prepared from the joints, thymus, peritoneal macrophages, splenic T cells, and splenic B cells of the recipient mice which were transferred with T cell-depleted BM cells. The BM cell RNA was prepared from untreated pX-Tg mice. ATg, arthritic Tg mice; NTg, nonarthritic Tg mice. The 181-base band represents the pX mRNA and the 191-base band represents the env mRNA. The mice were sacrificed at the age of 28–30 wk, 24 wk after the transplantation.

 
RF and Ig levels in the circulation and the expression of cytokine genes in the joints increased in mice transferred with Tg immune cells

Because high levels of serum Ig and RF relevant to autoimmunity are characteristic of pX-Tg mice, these autoimmune parameters were determined. Total IgG levels (Fig. 4GoA), total IgM levels (Fig. 4GoB), and IgG class RF levels (Fig. 4GoC) in [Tg->non-Tg] mice were significantly higher than those in non-Tg control mice. In contrast, these Ig levels in [non-Tg->Tg] mice significantly reduced compared with those in arthritic Tg mice, being nearly equal to the levels in nonarthritic Tg mice. These serological data suggest involvement of autoimmunity in the development of arthritis in [Tg->non-Tg] mice.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 4. Serum Ig and RF levels after transplantation with immune cells. A, Total IgG; B, total IgM; C, IgG class RF. BM, Ig levels in T cell-depleted BM cell-transferred recipients; BM+S, Ig levels in BM plus spleen cell-transferred recipients; ATg, arthritic Tg mice; NTg, nonarthritic Tg mice; non-Tg, non-Tg mice. Columns indicate the means, bars indicate the SD, and circles indicate individual values. {circ}, Nonarthritic mice; •, arthritic mice. The mice were sacrificed at the age of 32–36 wk, 26–30 wk after the transplantation. *, p < 0.05; **, p < 0.01, compared with untreated ATg; {dagger}, p < 0.05; {dagger}{dagger}, p < 0.01, compared with untreated non-Tg mice by F test.

 
Various proinflammatory cytokines are abundantly expressed in the affected joints of RA patients, and the same kinds of gene are also activated in the joints of pX-Tg mice. These proinflammatory genes, especially IL-1ß, IL-6, and TNF-{alpha} genes, were activated in the affected joints of [Tg->non-Tg] and [Tg->Tg] mice as in arthritic Tg mice (18), compared with the nonarthritic joints of [non-Tg->Tg] and non-Tg mice (Fig. 5Go). However, their expression in the spleen was not correlated to the arthritis. The expression of these cytokines in the nonarthritic joints of [non-Tg(BM + S)->Tg] and [non-Tg(BM) ->Tg] mice was not augmented (Fig. 5Go), in spite of the pX expression in the joints of these mice (Fig. 3Go). Thus, it was suggested that pX-gene expression in the resident cells in the joints is not directly involved in the activation of cytokine expression in the affected joints.



View larger version (79K):
[in this window]
[in a new window]
 
FIGURE 5. Cytokine gene expression in mice transplanted with BM cells or BM plus spleen cells. Expression of the IL-1{alpha}, IL-1ß, IL-6, and TNF-{alpha} mRNA in the joints and the spleen was analyzed by Northern blot hybridization. ß-Actin was used as a control. The mice were sacrificed at the age of 16–20 wk, 12 wk after the transplantation. S, Spleen cells.

 
Development of arthritis greatly reduced in nu/nu-pX-Tg mice

To elucidate roles of T cells in the development of arthritis in pX-Tg mice, the incidence and severity of the disease were compared between nu/nu (athymic)- and nu/+ (euthymic)-pX-Tg mice. As shown in Table IIGo, the incidence of arthritis was clearly lower in homozygous nude mice than in heterozygous ones. The histology of the nonarthritic joints was normal when examined by a microscope (Fig. 6GoA). The incidence in heterozygous mice was not significantly different between female and male mice. Although only female nu/nu mice developed arthritis, the difference is statistically not significant. The average incidences in heterozygous and homozygous mice including both female and male were 56.2 and 4.3% at 3 mo and 84.2 and 13.6% at 5 mo of age, respectively. The severity scores were also low in nude mice compared with euthymic mice, because fewer paws were affected in those mice. These results suggest that T cell immunity plays a crucial role in the development of arthritis in pX-Tg mice.


View this table:
[in this window]
[in a new window]
 
Table II. Incidence of arthritis in athymic nu/nu pX-Tg mice

 


View larger version (83K):
[in this window]
[in a new window]
 
FIGURE 6. Histological appearance of the joints of nu/nu-pX-Tg mice. A, Nonarthritic ankle joint (female, 22 wk old). No remarkable changes were detected in a macroscopically normal mouse. x20. B, Arthritic ankle joint (female, 23 wk old). Destructive changes of the joint, associated with proliferation of the synovial (S) lining cells (arrowheads), infiltration of inflammatory cells, and erosion of the articular cartilage. x20. C, Enlargement of B. Accumulation of eosinophilic polymorphonuclear cells in the synovia was evident. x400.

 
Small but significant numbers of nu/nu mice developed arthritis in which erosion of the articular cartilage, proliferation of synovial cells, and infiltration of neutrophils were observed in the joints (Fig. 6Go, B and C). In this respect, we found that many CD3+ T cells was present in nu/nu mouse lymph nodes at the age of 5 mo; ~30% of the lymph node cells were T cells in nu/nu mice, in contrast to 60% in wild-type mice. However, the RF levels in nu/nu-pX-Tg mice were not elevated even after development of arthritis (Fig. 7Go). These observations indicate that RF is not necessarily required for the development of arthritis in these mice.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 7. Serum RF levels in nu/nu-pX-Tg mice. ATg, arthritic Tg mice; NTg, nonarthritic Tg mice; non-Tg, non-Tg mice. Columns indicate the means, bars indicate the SD, and circles indicate individual values. {circ}, Nonarthritic mice; •, arthritic mice. The mice were sacrificed at the age of 5 mo. **, p < 0.01, compared with non-Tg mice by F test.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study, to investigate the etiopathogenesis of the arthritis in pX-Tg mice, we have conducted reciprocal replacement of the immune cells between pX-Tg and normal mice and found that transplantation of BM cells from pX-Tg mice into lethally irradiated non-Tg mice caused autoimmunity and arthritis, and conversely, introduction of non-Tg mouse BM cells suppressed the onset of the disease completely. These findings showed that BM cells and their derivatives are abnormal in pX-Tg mice and that these cells are enough to cause autoimmunity and arthritis in these mice.

The arthritis was not caused by the T cells that were contaminated in BM cell preparations, because we depleted T cells by treating BM cells with anti-Thy-1.2 Ab and complement before transfer of the cells. Moreover, addition of spleen cells in which large amounts of T cells were present to the BM preparation did not increase the incidence of arthritis. We also tried to induce arthritis by transferring spleen cells into nude mice, but we have never succeeded (data not shown). Thus, these observations suggest that the disease is not caused by the abnormal education of T cells in the periphery but by the disorder in the stem cells.

Under our conditions, pX gene expression was observed in T cells, B cells, and macrophages when BM cells from Tg mice were transplanted into lethally irradiated non-Tg mice. However, the expression disappeared completely both in T cells, B cells, and macrophages after transfer with non-Tg mouse BM cells into irradiated Tg mice. These results indicate that the immune system of the recipient mice was completely substituted with the donor cell-derived population. Suppression of arthritis was better in [non-Tg (BM + S)->Tg] mice than in [non-Tg (BM)->Tg] mice, probably because the immune system could be reconstituted earlier by the presence of spleen cells. In this connection, it is known that presence of T cells in donor bone marrow inocula leads to predominant repopulation with donor lymphocytes in recipient mice (31).

In contrast, the pX gene expression was still observed in Tg mouse joints transferred with non-Tg mouse BM cells. Because the pX gene is expressed in cells other than immune cells, including muscle and synovial cells in pX-Tg mice (17), this residual expression of the pX gene is considered to be originated from the resident cells in the joints. This pX gene expression in the joints did not cause arthritis providing the BM-derived cells were normal. Not only the histology but also the autoantibody levels and cytokine production in the joints were normal in these normal BM cell-transferred Tg mice. These findings indicate that synovial cell overgrowth in the affected joints is not the direct effect of the pX gene expression in the synovial cells. Cytokine overproduction also seems not to be caused by the resident cells in the joints, although it is quite possible that BM-derived cells such as macrophage or type A cells in the synovial tissues participate in the production of inflammatory cytokines (32).

Accordingly, these findings, together with the observations that 1) a considerably long time (>15 wk), i.e., enough to replace the immune system (33), is required before onset of the disease after transplantation of Tg BM cells, 2) the effects of the BM transplantation last for at least 26 wk, and 3) transplantation of Tg T cells only could not induce arthritis, and conversely, T cells from normal mice could not prevent development of the disease (data not shown) suggest that the autoimmunity in pX-Tg mice is not caused by a T cell aberration resulting from abnormal T cell education but by a stem cell disorder. Stem cell disorder was also suggested in autoimmune-prone mice such as MRL/MP-lpr/lpr, (NZB x NZW)F1 mice, and BXSB mice. Autoimmune diseases in these mice are also prevented from developing or are completely corrected even after their development by transplantation of normal BM cells (34, 35).

We found that development of arthritis was suppressed in athymic nu/nu-pX-Tg mice, suggesting a crucial role of T cells in the pathogenesis. These observations are consistent with the autoimmune nature of the disease. In this connection, we recently found that pX-Tg mouse T cells were refractory against Fas-mediated apoptosis, as is the case in lpr/lpr mice (19). Thus, the stem cell disorder seems to manifest at least in T cells.

However, a small but significant number of athymic nu/nu-pX-Tg mice developed arthritis. This observation suggests that the pX gene can induce arthritis without involvement of T cells. Another possibility is that extrathymically developed T cells in aged nu/nu mice are involved in the development of the disease. However, because RF levels were not elevated in nu/nu-pX-Tg mice, these T cells seem to be immunologically unresponsive. Consistent with this notion, Gutierrez-Ramos et al. (36) reported that peripherally developed T cells in nu/nu mice are anergic against self components, in spite of the defect in negative selection in the thymus. Therefore, the defects in pX-Tg-T cells could be supplementary, and the autoimmunity may only accelerate the disease.

In this context, the observation that cytokine gene expression, including IL-1, IL-6, and TNF-{alpha}, is augmented in the Tg BM cell-transferred joints suggests that Tg BM-derived cells, such as type A synovial cells which have some characteristics similar to those of macrophages, distribute in the joints (32) and produce these cytokines. We propose that this activation of inflammatory cytokine genes by Tax in the joints may trigger the inflammation by inducing other cytokines, chemokines, chemical mediators, and proteases. This should cause swelling of the joint, infiltration of neutrophils into synovial tissues, and destruction of the bony structure by activating osteoclasts without involvement of immune reaction. Actually, it was reported that overproduction of TNF-{alpha} in the joints caused joint destruction without infiltration of immune cells (22). Thus, the arthritis seems to be induced by two steps: 1) the triggering by the cytokine overproduction; and 2) acceleration by the autoimmune reaction against synovial components. Cytokine overproduction may also contribute to the development of autoimmunity by enhancing recruitment of immune cells, augmenting expression of MHC genes, and activating T cells in anergy (37). These mechanisms may also explain why these mice develop such a tissue-specific autoimmunity.

Our study shows that T cell-dependent autoimmunity plays crucially important roles in manifesting symptoms of arthritis. We are now examining the roles of cytokines and autoimmunity in the development of arthritis by producing cytokine knockout mice and tissue-specific tax-Tg mice.


    Acknowledgments
 
We thank Drs. Akio Matsuzawa, Masahide Asano (The Institute of Medical Science, University of Tokyo), Susumu Ikehara (Kansai Medical University, Moriguchi, Japan), Shin-ichiro Shimada, Masanobu Nanno (Yakult Central Institute for Microbiological Research, Kunitachi, Japan), and Yuko Kioka (Takeda Chemical Industries, Osaka, Japan) for their advice and valuable discussion; and all of the laboratory members for excellent animal care.


    Footnotes
 
1 This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Ministry of Health and Welfare of Japan, Core Research for Engineering, Science, and Technology, and Pioneering Research in Biotechnology. Back

2 Address correspondence and reprint requests to Dr. Yoichiro Iwakura, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. E-mail address: Back

3 Abbreviations used in this paper: RA, rheumatoid arthritis; IIC, type II collagen; HTLV-I, human T cell leukemia virus type I; LTR, long terminal repeat; Tg, transgenic; pX-Tg, HTLV-I env-pX region-introduced transgenic; RF, rheumatoid factor. Back

Received for publication October 5, 1998. Accepted for publication August 27, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Vaughan, J. H.. 1993. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 36:1.[Medline]
  2. Andriopoulos, N. A., J. Mestecky, E. J. Miller, E. L. Bradley. 1976. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 19:613.[Medline]
  3. Clague, R. B., M. J. Shaw, P. J. Holt. 1980. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann. Rheum. Dis. 39:201.[Abstract/Free Full Text]
  4. Tarkowski, A., L. Klareskog, H. Carlsten, P. Herberts, W. Koopman. 1989. Secretion of antibodies to type I and type II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 32:1087.[Medline]
  5. van Eden, W., J. E. R. Thole, R. van der Zee, A. Noordzij, J. D. A. van Embden, E. J. Hensen, I. R. Cohen. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331:171.[Medline]
  6. Sugamura, K., Y. Hinuma. 1993. Human retroviruses: HTLV-I and HTLV-II. ed. In The RetroViridea Vol. 2:399. Plenum, New York.
  7. Yoshida, M., T. Suzuki, J. Fujisawa, H. Hirai. 1995. HTLV-I oncoprotein tax and cellular transcription factors. Curr. Top. Microbiol. Immunol. 193:131.
  8. Yoshida, M.. 1993. HTLV-I tax: regulation of gene expression and disease. Trends Microbiol. 1:131.[Medline]
  9. Maruyama, M., H. Shibuya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343.[Medline]
  10. Siekevitz, M., M. B. Feinberg, N. Holbrook, F. Wong-Staal, W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc. Natl. Acad. Sci. USA 84:5389.[Abstract/Free Full Text]
  11. Kim, S.-J., J. H. Kehrl, J. Burton, C. L. Tendler, K.-T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, A. B. Roberts. 1990. Transactivation of the transforming growth factor 1 (TGF-ß1) gene by human T lymphotropic virus type I Tax: a potential mechanism for the increased production of TGF-ß 1 in adult T cell leukemia. J. Exp. Med. 172:121.[Abstract/Free Full Text]
  12. Miyatake, S., M. Seiki, M. Yoshida, K. Arai. 1988. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte- macrophage colony-stimulating factor gene through a common DNA element. Mol. Cell. Biol. 8:5581.[Abstract/Free Full Text]
  13. Inoue, J., M. Seiki, T. Taniguchi, S. Tsuru, M. Yoshida. 1986. Induction of interleukin 2 receptor gene expression by p40x-encoded by human T-cell leukemia virus type I. EMBO J. 5:2883.[Medline]
  14. Green, J. E., C. G. Begley, D. K. Wagner, T. A. Waldmann, G. Jay. 1989. trans-Activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol. Cell. Biol. 9:4731.[Abstract/Free Full Text]
  15. Fujii, M., P. Sassone-Corsi, I. M. Verma. 1988. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 85:8526.[Abstract/Free Full Text]
  16. Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, M. Seiki. 1991. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene 6:1023.[Medline]
  17. Iwakura, Y., M. Tosu, E. Yoshida, M. Takiguchi, K. Sato, I. Kitajima, K. Nishioka, K. Yamamoto, T. Takeda, M. Hatanaka, H. Yamamoto, T. Sekiguchi. 1991. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026.[Abstract/Free Full Text]
  18. Iwakura, Y., S. Saijo, Y. Kioka, J. Yamada, K. Itagaki, M. Tosu, M. Asano, Y. Kanai, K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588.[Abstract]
  19. Kishi, S., S. Saijo, M. Arai, S. Karasawa, S. Ueda, M. Kannagi, Y. Iwakura, M. Fujii, S. Yonehara. 1997. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J. Exp. Med. 186:57.[Abstract/Free Full Text]
  20. Nagata, S., P. Golstein. 1995. The Fas death factor. Science 267:1449.[Abstract/Free Full Text]
  21. Iwakura, Y., M. Tosu, E. Yoshida, S. Saijo, J. Nakayama-Yamada, K. Itagaki, M. Asano, H. Siomi, M. Hatanaka, T. Takeda, T. Nunoya, S. Ueda, H. Shibuta. 1994. Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type-I tax gene. Virus Genes 9:161.
  22. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, G. Kollias. 1991. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J. 10:4025.[Medline]
  23. Pettipher, E. R., G. A. Higgs, B. Hederson. 1986. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 83:8749.[Abstract/Free Full Text]
  24. Firestein, G. S., N. J. Zvaifler. 1992. Rheumatoid arthritis: a disease of disordered immunity. ed. Inflammation: Basic Principles and Clinical Correlates 959. Raven Press, New York.
  25. Wooley, P. H., H. S. Luthra, J. M. Stuart, C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody corre-lates. J. Exp. Med. 154:688.[Abstract/Free Full Text]
  26. Chomczynski, P., N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.[Medline]
  27. Lomedico, P. T., U. Gubler, C. P. Hellmann, M. Dukovich, J. G. Giri, Y.-C. E. Pan, K. Collier, R. Semionow, A. O. Chua, S. B. Mizel. 1984. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458.[Medline]
  28. Gray, P. W., D. Glaister, E. Chen, D. V. Goeddel, D. Pennica. 1986. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1ß. J. Immunol. 137:3644.[Abstract]
  29. Chiu, C.-P., C. Moulds, R. L. Coffman, D. Rennick, F. Lee. 1988. Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc. Natl. Acad. Sci. USA 85:7099.[Abstract/Free Full Text]
  30. Pennica, D., J. S. Hayflick, T. S. Bringman, M. A. Palladino, D. V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:6060.[Abstract/Free Full Text]
  31. Sykes, M., M. Sheard, D. H. Sachs. 1988. Effects of T cell depletion in radiation bone marrow chimeras. J. Immunol. 141:2282.[Abstract]
  32. Dreher, R.. 1982. Origin of synovial type A cells during inflammation an experimental approach. Immunobiology 161:232.[Medline]
  33. Ogasawara, K., N. Fukushi, H. Arase, C. Iwabuchi, S. Hatakeyama, K. Iwabuchi, R. A. Good, K. Onoe. 1990. Sequential analysis of thymocyte differentiation in fully allogenetic bone marrow chimera in mice. Immnobiology 180:149.
  34. Ikehara, S., R. A. Good, T. Nakamura, K. Sekita, S. Inoue, M. M. Oo, E. Muso, K. Ogawa, Y. Hamashima. 1985. Rationale for bone marrow transplantation in the treatment of autoimmune disease. Proc. Natl. Acad. Sci. USA 82:2483.[Abstract/Free Full Text]
  35. Himeno, K., R. A. Good. 1988. Marrow transplantation from tolerant donors to treat and prevent autoimmune disease in BXSB mice. Proc. Natl. Acad. Sci. USA 82:2483.
  36. Gutierrez-Ramos, J. C., I. Moreno de Alboran, C. Martinez. 1992. In vivo administration of interleukin-2 turns on anergic self-reactive T cells and leads to sutoimmune disease. Eur. J. Immunol. 22:2867.[Medline]
  37. Nakata, Y., K. Matsuda, A. Uzawa, M. Nomura, M. Akashi, G. Suzuki. 1995. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo. J. Immunol. 155:4231.[Abstract]



This article has been cited by other articles:


Home page
Int ImmunolHome page
Y. Kobari, Y. Misaki, K. Setoguchi, W. Zhao, Y. Komagata, K. Kawahata, Y. Iwakura, and K. Yamamoto
T cells accumulating in the inflamed joints of a spontaneous murine model of rheumatoid arthritis become restricted to common clonotypes during disease progression
Int. Immunol., January 1, 2004; 16(1): 131 - 138.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saijo, S.
Right arrow Articles by Iwakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saijo, S.
Right arrow Articles by Iwakura, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS